[Guidelines for the medical treatment of non-neurological urinary incontinence in women].
Although it is not possible to use medications on the anatomic features of incontinence, a better comprehension of the physiopathology of miction impairment can lead to pharmacological treatment of female urinary incontinence. However, analysis of the literature shows that few publications are methodologically satisfactory, nor are they comparable. In presence of stress urinary incontinence, vaginal hormone treatment must be provided if the patient presents vaginal atrophy with physical therapy or surgery planned. Use of noradrenaline recapture inhibitors and serotonin cannot be recommended today. There are no indications for alpha-adrenergic treatments. For urge incontinence treatment, use of anticholinergics should be provided, possibly associated with vaginal hormone treatment if the patient presents vaginal atrophy.
Conquy
S
S
Clinique Urologique, CHU Cochin, 27, rue du Faubourg Saint-Jacques, 75694 Paris cedex 14, France. sophie.conquy@cch.aphp.fr
D018680:Cholinergic Antagonists / Q000627:therapeutic use; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D014549:Urinary Incontinence / Q000628:therapy*
D018680:Cholinergic Antagonists; D017367:Selective Serotonin Reuptake Inhibitors